- Report
- March 2024
- 183 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 199 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- January 2024
- 150 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- April 2024
- 194 Pages
Global
From €4808EUR$4,950USD£4,147GBP
- Report
- October 2023
- 150 Pages
Global
From €2427EUR$2,499USD£2,094GBP
- Report
- February 2024
- 196 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- February 2024
- 213 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Report
- April 2024
- 152 Pages
Global
From €3836EUR$3,950USD£3,310GBP
- Report
- June 2023
- 200 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- February 2024
- 188 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- February 2024
- 110 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- March 2024
- 200 Pages
Global
From €4031EUR$4,150USD£3,477GBP
- Report
- February 2024
- 177 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- April 2022
- 191 Pages
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more